CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that
it will report its second quarter 2018 financial results after the
market close on Monday, July 30, 2018. The Company will host a
conference call the following morning, Tuesday, July 31, 2018, at 9:00
a.m. ET to discuss these results.
To participate in the conference call, dial 800-219-7113 (domestic) or
574-990-1030 (international) using the passcode 7865703.
To access the conference call via webcast, visit the “Investors” section
of Medpace’s website at investor.medpace.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the
“Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available from 12:00 p.m. ET on Tuesday,
July 31, 2018 until 12:00 p.m. ET on Tuesday, August 14, 2018. To hear
this recording, dial 855-859-2056 (domestic) or 404-537-3406
(international) using the passcode 7865703.
Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical and medical
device industries. Medpace’s mission is to accelerate the global
development of safe and effective medical therapeutics through its
high-science and disciplined operating approach that leverages
regulatory and therapeutic expertise across all major areas including
oncology, cardiology, metabolic disease, endocrinology, central nervous
system and anti-viral and anti-infective. Headquartered in Cincinnati,
Ohio, Medpace employs approximately 2,600 people across 36 countries.